Management of Persistent Pruritus and Lichenoid Reaction Secondary to Nivolumab With Narrowband Ultraviolet B Phototherapy

Immune checkpoint inhibitors targeting the programmed cell death receptor 1 (PD-1) are increasingly used to treat several malignancies, with the most common adverse event being cutaneous toxicity. We report the case of a 68-years-old man with stage IV non-small cell lung cancer treated with nivoluma...

Descripción completa

Detalles Bibliográficos
Autores principales: Donaldson, Marie, Owen, Joshua L., Chae, Young K., Choi, Jennifer N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167527/
https://www.ncbi.nlm.nih.gov/pubmed/30319970
http://dx.doi.org/10.3389/fonc.2018.00405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167527/
https://www.ncbi.nlm.nih.gov/pubmed/30319970
http://dx.doi.org/10.3389/fonc.2018.00405

Ejemplares similares